# Regadenoson R-T Perfusion Imaging Trial

> **NCT00837369** · PHASE1 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 100 (actual)

## Conditions studied

- Coronary Artery Disease
- Myocardial Perfusion Abnormalities

## Interventions

- **DRUG:** Regadenoson

## Key facts

- **NCT ID:** NCT00837369
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-07
- **Primary completion:** 2011-03-01
- **Final completion:** 2011-12-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-12-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837369, "Regadenoson R-T Perfusion Imaging Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00837369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*